H.C. Wainwright Upgrades Fulcrum Therapeutics (FULC) to Buy; 'Removal of Clinical Hold Lights a Clearer Pathway to SCD'
Tweet Send to a Friend
(Updated - August 23, 2023 6:50 AM EDT)
H.C. Wainwright analyst Andrew Fein upgraded Fulcrum Therapeutics (NASDAQ: FULC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Andrew Fein upgraded Fulcrum Therapeutics (NASDAQ: FULC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
